Scleral Proteome in Noninfectious Scleritis Unravels Upregulation of Filaggrin-2 and Signs of Neovascularization

Purpose Scleritis is a severe inflammatory ocular disorder with unknown pathogenesis. We investigated healthy sclera as well as sclera affected by noninfectious scleritis for differentially expressed proteins using a mass spectrometry approach. Methods We collected scleral samples of enucleated eyes due to severe noninfectious scleritis (n = 3), and control scleral tissues (n = 5), all exenterated eyes for eyelid carcinomas (n = 4), or choroidal melanoma (n = 1) without scleral invasion. Samples were prepared for the nano liquid-chromatography mass spectrometer (LC-MS), data were analyzed using proteomics software (Scaffold), and is available via ProteomeXchange (identifier PXD038727). Samples were also stained for immuno-histopathological evaluation. Results Mass spectrometry identified 629 proteins within the healthy and diseased scleral tissues, whereof collagen type XII, VI, and I were the most abundantly expressed protein. Collagen type II-XII was also present. Filaggrin-2, a protein that plays a crucial role in epidermal barrier function, was found upregulated in all scleritis cases. In addition, other epithelial associated proteins were upregulated (such as keratin 33b, 34, and 85, epiplakin, transglutaminase-3, galectin 7, and caspase-14) in scleritis. Further, upregulated proteins involved in regulation of the cytoskeleton (vinculin and myosin 9), and housekeeping proteins were found (elongation factor-2 and cytoplasmic dynein 1) in our study. Upregulation of filaggrin-2 and myosin-9 was confirmed with immunohistochemistry, the latter protein showing co-localization with the endothelial cell marker ETC-related gene (ERG), indicating neovascularization in scleral tissue affected by scleritis. Conclusions We found upregulation of filaggrin-2 and signs of neovascularization in scleral tissue of patients with noninfectious scleritis. Further research, ideally including more scleritis cases, is needed to validate our findings.

[1]  S. H. van der Burg,et al.  Dataset from a proteomics analysis of tumor antigens shared between an allogenic tumor cell lysate vaccine and pancreatic tumor tissue. , 2022, Data in brief.

[2]  A. Brazma,et al.  The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..

[3]  J. Hori,et al.  Immunopathological Analysis of a Mouse Model of Arthritis-Associated Scleritis and Implications for Molecular Targeted Therapy for Severe Scleritis , 2021, International journal of molecular sciences.

[4]  Amin Mousavi Khaneghah,et al.  Investigation of the role of IL18, IL-1β and NLRP3 inflammasome in reducing expression of FLG-2 protein in Psoriasis vulgaris skin lesions , 2021, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[5]  W. Robinson,et al.  Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis , 2021, Frontiers in Immunology.

[6]  M. Stepp,et al.  Immune responses to injury and their links to eye disease: Immune responses to wounding in the eye. , 2021, Translational research : the journal of laboratory and clinical medicine.

[7]  Ning Wang,et al.  Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells , 2020, Cancer Research.

[8]  M. Furue.  Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis , 2020, International journal of molecular sciences.

[9]  H. Aghamollaei,et al.  Review of proteomics approach to eye diseases affecting the anterior segment. , 2020, Journal of proteomics.

[10]  A. Warnatsch,et al.  Histones, DNA, and Citrullination Promote Neutrophil Extracellular Trap Inflammation by Regulating the Localization and Activation of TLR4. , 2020, Cell reports.

[11]  M. Patel,et al.  Context-Dependent Role of Vinculin in Neutrophil Adhesion, Motility and Trafficking , 2019, Scientific Reports.

[12]  A. Dick,et al.  Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study , 2019, British Journal of Ophthalmology.

[13]  S. Pinto,et al.  Proteomics and Visual Health Research: Proteome of the Human Sclera Using High-Resolution Mass Spectrometry. , 2019, Omics : a journal of integrative biology.

[14]  M. Hankins,et al.  Histopathological evaluation of scleritis , 2019, Journal of Clinical Pathology.

[15]  S. Davoudi,et al.  Association of Low Vitamin D Levels with Noninfectious Uveitis and Scleritis , 2019, Ocular immunology and inflammation.

[16]  O. Sarig,et al.  Filaggrin 2 Deficiency Results in Abnormal Cell-Cell Adhesion in the Cornified Cell Layers and Causes Peeling Skin Syndrome Type A. , 2018, The Journal of investigative dermatology.

[17]  Samara L. Reck-Peterson,et al.  The cytoplasmic dynein transport machinery and its many cargoes , 2018, Nature Reviews Molecular Cell Biology.

[18]  Pingbo Zhang,et al.  The proteome of normal human retrobulbar optic nerve and sclera , 2016, Proteomics.

[19]  A. Pandey,et al.  Synovial fluid proteome in rheumatoid arthritis , 2016, Clinical Proteomics.

[20]  M. Mesquida,et al.  Interleukin‐22 serum levels are elevated in active scleritis , 2016, Acta ophthalmologica.

[21]  M. Volin,et al.  The pathogenic role of angiogenesis in rheumatoid arthritis , 2015, Angiogenesis.

[22]  R. Toes,et al.  Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis , 2015, Nature Communications.

[23]  D. Wakefield,et al.  Scleritis: Immunopathogenesis and molecular basis for therapy , 2013, Progress in Retinal and Eye Research.

[24]  Pilar Martín,et al.  Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis. , 2013, The Journal of clinical investigation.

[25]  P. Vandenabeele,et al.  Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. , 2011, The Journal of investigative dermatology.

[26]  M. N. Nakatsu,et al.  Keratin 13 is a more specific marker of conjunctival epithelium than keratin 19 , 2011, Molecular vision.

[27]  E. Nelson,et al.  New insights into vinculin function and regulation. , 2011, International review of cell and molecular biology.

[28]  H. Yoshioka,et al.  Epiplakin accelerates the lateral organization of keratin filaments during wound healing. , 2010, Journal of dermatological science.

[29]  J. Schröder,et al.  Molecular Identification and Expression Analysis of Filaggrin-2, a Member of the S100 Fused-Type Protein Family , 2009, PloS one.

[30]  H. Goto,et al.  Immunopathology of necrotising scleritis , 2008, British Journal of Ophthalmology.

[31]  H. Lee,et al.  Expression of Tumor Necrosis Factor Alpha and Matrix Metalloproteinase-9 in Surgically Induced Necrotizing Scleritis , 2006, Ophthalmic Research.

[32]  C. D. Yoo,et al.  Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis , 2005, Experimental & Molecular Medicine.

[33]  P. Högger,et al.  Interaction of soluble CD163 with activated T lymphocytes involves its association with non‐muscle myosin heavy chain type A , 2004, Immunology and cell biology.

[34]  F. Rastinejad,et al.  The emerging structural understanding of transglutaminase 3. , 2004, Journal of structural biology.

[35]  E. Rappaport,et al.  Microarray analysis of gene expression in human donor sclera. , 2004, Molecular vision.

[36]  N. Rao,et al.  Scleritis: a clinicopathologic study of 55 cases. , 1999, Ophthalmology.

[37]  D. Wakefield,et al.  Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. , 1997, The American journal of pathology.

[38]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[39]  A. Puren,et al.  Serum Interleukin (IL‐1β) in Patients with Diffuse Scleritis , 1992 .

[40]  R. Young,et al.  Ultrastructural changes in scleral proteoglycans precede destruction of the collagen fibril matrix in necrotizing scleritis , 1988, Histopathology.

[41]  N. Rao,et al.  Necrotizing Scleritis: A Clinico-pathologic Study of 4l Cases , 1985 .

[42]  R. Young,et al.  Microscopical studies of necrotising scleritis. II. Collagen degradation in the scleral stroma. , 1984, The British journal of ophthalmology.

[43]  P. G. Watson,et al.  EPISCLERITIS AND SCLERITIS. I , 1968 .

[44]  European Journal of Immunology , 2022 .